Amedica to Present Advantages of Silicon Nitride Implants at 2016 Brazilian Spine Congress

SALT LAKE CITY, Feb. 23, 2016 (GLOBE NEWSWIRE) — Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce its participation in the 2016 Brazilian Spine Congress occurring March 3-4, 2016 in Sao Paulo, Brazil.

“Brazil has been an emerging growth opportunity for us since achieving clearance during the third quarter of last year thanks in part to our Brazilian partner, Sintex Medical,” said Dr. Sonny Bal, Chairman and Chief Executive Officer. “We feel that the content we plan to present, and the surgeons with whom we will be meeting in Sao Paulo will strengthen this additional sales channel through the balance of this year.”

“With the limited options currently available to Brazilian surgeons, Brazil reflects a market opportunity for new technologies in spinal products and surgical techniques,” said Daniel Bolotnicki, Chief Executive Officer of Sintex Medical. “We’ve experienced very positive feedback with the silicon nitride fusion devices since our initial launch last quarter, due in part to the unique osteoconductive, anti-infective, and superior imaging properties of silicon nitride. We anticipate further geographic expansion, and expect to capture a significant share of the market from legacy PEEK cages that have inherent limitations. We are confident the Brazilian market will understand the superiority of silicon nitride, in terms of positively affecting patient outcomes.”

“I look forward to presenting and sharing the clinical outcomes I’ve experienced while using silicon nitride the past several years,” said Dr. Graham C. Calvert, M.D., Mississippi Sports Medicine and Orthopedic Center. “Silicon nitride truly is a breakthrough material and contains a unique surface biochemistry which ensures reliable osseointegration, while also inhibiting bacterial biofilm adhesion.”

The 16th annual Brazilian Spine Congress attracts leading clinicians, surgeons, and scientists from the Americas who come together to present the latest innovative musculoskeletal clinical and scientific research. For more information on the Brazilian Spine Congress, please visit http://cirurgiaespinhal.com.br/2016/.

About Amedica Corporation
Amedica is focused on the development and application of interbody implants manufactured with medical-grade silicon nitride ceramic. Amedica markets spinal fusion products and is developing a new generation of wear- and corrosion-resistant implant components for hip and knee arthroplasty as well as dental applications. The Company’s products are manufactured in its ISO 13485 certified manufacturing facility and through its partnership with Kyocera, one of the world’s largest ceramic manufacturers. Amedica’s spine products are FDA-cleared, CE-marked, and are currently marketed in the U.S. and select markets in Europe and South America through its distributor network and its growing OEM and private label partnerships.

For more information on Amedica or its silicon nitride material platform, please visit www.amedica.com.

Read more: http://www.virtual-strategy.com/2016/02/23/amedica-present-advantages-silicon-nitride-implants-2016-brazilian-spine-congress#ixzz417TBi0Jg
Follow us: @virtualstrategy on Twitter | VirtualStrategyMagazine on Facebook
Read more at http://www.virtual-strategy.com/2016/02/23/amedica-present-advantages-silicon-nitride-implants-2016-brazilian-spine-congress#axzz416QrABTu#fZUbszCgGqRdjuyw.99

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button